“We are moving toward making Puerto Rico a leader in clinical research and opening new opportunities for our patients, researchers, healthcare professionals, and veterans.” Executive Order 2026-037 will create a comprehensive assessment regarding the feasibility and advisability of establishing a “Pilot Clinical Research Program for Emerging Therapies.” “Through this Executive Order, we are moving toward making Puerto Rico a leader in clinical research and opening new opportunities for our patients, researchers, healthcare professionals, and veterans,” she added. Advocacy organizations across the island, including the Colectivo Psicodélico de Puerto Rico (also known as the Puerto Rico Psychedelic Collective) heralded the executive order as a watershed moment for Puerto Rico’s psychedelic ambitions. A prominent component of the executive order is its dedicated focus on Puerto Rican military veterans.